Clinical Implications of Elevated Antiphospholipid Antibodies in Adult Patients with Primary Immune Thrombocytopenia-Reference-Cited by-同舟云学术

Clinical Implications of Elevated Antiphospholipid Antibodies in Adult Patients with Primary Immune Thrombocytopenia

Published:2011 Issue:4 Volume:26 Page:449
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Yang Young-Joon¹,Yun Gak-Won²,Song Ik-Chan²,Baek Seung-Woo²,Lee Kyu-Seop²,Ryu Hye Won²,Lee Myung-Won²,Lee Hyo-Jin²,Yun Hwan-Jung²,Kim Samyong²,Jo Deog-Yeon²

Affiliation:

1. Department of Internal Medicine, Daejeon Saint Mary's Hospital, The Catholic University of Korea School of Medicine, Daejeon, Korea.

2. Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.

Publisher

Korean Association of Internal Medicine

Link

http://synapse.koreamed.org/pdf/10.3904/kjim.2011.26.4.449

Reference18 articles.

1. International consensus report on the investigation and management of primary immune thrombocytopenia

2. The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients

3. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

4. Primary Antiphospholipid Antibody Syndrome: How Certain Can You Be of the Diagnosis?

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary Evans Syndrome Presenting With Lupus Anticoagulant;Cureus;2024-07-06

2. Immune Thrombocytopenia Could be an Independent Clinical Phenotype of Antiphospholipid Syndrome: A Prospective Cohort Study;Rheumatology and Therapy;2023-02-20

3. Splenectomy outcomes in patients with autoimmune cytopenias and persistent antiphospholipid antibodies;Transfusion;2022-10-08

4. Thrombocytopenia in primary antiphospholipid syndrome: association with prognosis and clinical implications;Rheumatology;2022-05-10

5. Update on diagnosis and treatment of immune thrombocytopenia;Expert Review of Clinical Pharmacology;2021-03-30